Frequency and relevance of concomitant diseases in elderly patients hospitalized for community acquired pneumonia

Autor: Đurić Mirna, Považan Đorđe, Sečen Nevena, Perin Branislav

Publikováno v: Srpski Arhiv za Celokupno Lekarstvo, Vol 137, Iss 11-12, Pp 619-626 (2009)

Introduction. Patients' age and concomitant diseases are relevant for the development and treatment outcome of pneumonia. Objective. To establish the frequency and relevance of concomitant diseases in patients over 65 years of age hospitalized for co

Externí odkaz: https://doaj.org/article/c5f43e6764c649118c87a4fbd9ec622e

Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study

Autor: Cho BC, Abreu DR, Hussein M, Cobo M, Patel AJ, Secen N, Lee KH, Massuti B, Hiret S, Yang JCH, Barlesi F, Lee DH, Ares LP, Hsieh RW, Patil NS, Twomey P, Yang X, Meng R, Johnson ML

Publikováno v: LANCET ONCOLOGY
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname

BACKGROUND: Targeted inhibition of the PD-L1-PD-1 pathway might be further amplified through combination of PD-1 or PD-L1 inhibitors with novel anti-TIGIT inhibitory immune checkpoint agents, such as tiragolumab. In the CITYSCAPE trial, we aimed to a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::150df734ff69c9b47d6f1c2e45c89351
https://linkinghub.elsevier.com/retrieve/pii/S1470-2045(22)00226-1

EP1.12-04 Can Prophylactic Cranial Irradiation Reduce Neurological Symptoms in Patients with Small Cell Lung Cancer?

Autor: Boskovic, T., Secen, N., Vitorovic, S., Sevo, M., Culibrk, T., Bokan, D.

Publikováno v: In Journal of Thoracic Oncology October 2019 14(10) Supplement:S1017-S1017

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.